[Frequency and characteristics of metabolic syndrome and insulin resistance in the first-degree relatives of persons with type 1 diabetes]. 2010

Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
Instituto Nacional de Endocrinología, La Habana, Cuba. diabetes@infomed.sld.cu

OBJECTIVE To determine the frequency of metabolic syndrome (MS) and insulin resistance (IR) in first-degree relatives of type 1 diabetic patients (FDR1) and to study the relationship between these two disorders and some clinical, biochemical and immunological characteristics. METHODS We studied 289 persons, of which 193 were children/adolescents and 96 were adults. Weight, height, waist and hip circumference, blood pressure, blood glucose, insulin, cholesterol, triglycerides, high-density lipoprotein-cholesterol, glutamic acid decarboxylase autoantibodies (GADA) and tyrosine phosphatase autoantibodies were determined. IR was assessed through the insulin resistance index (HOMA-IR). The criteria of the World Health Organization for adults and the Cuban consensus for children and adolescents were used to define MS. RESULTS The prevalence of MS in child and adolescent FDR1 was 5.7% (11/193) while IR was found in 24.9% (48/193). For adult FDR1, the frequency of MS was 6.2% (6/96) and that of IR was 14.6% (14/96). Interestingly, an association was found between IR and MS in adults but not in children and adolescents. IR was more frequent in children and adolescents than in adults (p<0.05). The presence of GADA was associated with IR but not with MS (p<0.05). CONCLUSIONS The frequency of MS in child and adolescent FDR1 was similar to that found in the general population according to studies using similar definitions of MS. In contrast, the frequency of MS in adults was lower than that reported in Cuba for the first-degree relatives of patients with type 2 diabetes. IR was not only associated with MS in first-degree relatives. The association of IR with the presence of GADA may reflect the fact that beta cell hyperactivity increases autoantigen expression.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
May 2003, Medical science monitor : international medical journal of experimental and clinical research,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
March 1999, Medicina clinica,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
January 2013, Journal of diabetes and its complications,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
April 2013, Acta diabetologica,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
June 2006, Autoimmunity,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
July 1999, Annals of internal medicine,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
January 2011, Diabetes & metabolic syndrome,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
January 2006, Ethnicity & disease,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
April 2008, Medicina clinica,
Eduardo Cabrera-Rode, and Sigrid Marichal, and Judith Parlá, and Celeste Arranz, and Roberto González, and Cecilia Pérez, and Pedro González, and Manuel L Vera, and Oscar Díaz-Horta
April 2006, Arquivos brasileiros de endocrinologia e metabologia,
Copied contents to your clipboard!